BerGenBio ASA (BRRGF) News Today

→ The Best AI Stock to Own in the World Today is Trading for Just $25 (From Banyan Hill Publishing) (Ad)

$0.03

0.00 (0.00%)

(As of 04/19/2024 ET)

Stock Analysis Analyst Forecasts Chart Headlines Short Interest

Source

Source	Headline
	BerGenBio Announces Initiation of Phase 2a in First Line Non-Small Lung Cancer Patients with a STK11 mutation finance.yahoo.com - March 20 at 6:55 PM
	BerGenBio Announces New Preclinical Data Indicating Broadened Potential for Bemcentinib to Treat Severe Respiratory Infections finance.yahoo.com - February 7 at 8:01 AM
	Gram Car Carriers Asa Share Price (GCC.OL) lse.co.uk - January 31 at 10:32 AM
	BerGenBio ASA (BRRGF) stock historical prices & data – Yahoo Finance sg.finance.yahoo.com - December 2 at 1:23 PM
	BerGenBio ASA BGBIO morningstar.com - November 18 at 7:13 PM
	BerGenBio Reports Third Quarter 2023 Financial Results finance.yahoo.com - November 14 at 1:35 AM
	BerGenBio Announces Data from Biomarker Analyses in 2L NSCLC finance.yahoo.com - November 6 at 8:42 AM
	BerGenBio Announces Poster Presentation at Upcoming SITC Meeting finance.yahoo.com - October 31 at 1:35 PM
	New Data on BerGenBio's Selective AXL Inhibitor Bemcentinib Released Today at 2023 ESMO Meeting finance.yahoo.com - October 23 at 9:59 AM
	Additional data on BerGenBio's selective AXL inhibitor bemcentinib to be presented at the 2023 ESMO meeting finance.yahoo.com - October 16 at 9:40 AM
	H.C. Wainwright Reaffirms Their Buy Rating on BerGenBio AS (BRRGF) markets.businessinsider.com - August 23 at 3:30 PM
	BerGenBio announces clinical data presentations highlighting the activity of its selective AXL inhibitor bemcentinib in Non-Small Cell Lung Cancer finance.yahoo.com - August 22 at 7:49 AM
	Coronation concert ballot misleading, says regulator ASA bbc.co.uk - August 15 at 7:31 AM
	BerGenBio ASA: Approval and publication of prospectus for the preferential Rights Issue finance.yahoo.com - May 26 at 1:43 PM
	BerGenBio AS (BRRGF) Gets a Buy from H.C. Wainwright markets.businessinsider.com - May 16 at 7:57 AM
	BerGenBio ASA: Proposed partially underwritten rights issue finance.yahoo.com - April 25 at 2:05 PM
	BerGenBio Announces First Patient Dosed in Phase 1b/2a Trial Evaluating Bemcentinib in 1st Line Non-Small Cell Lung Cancer with STK11 Mutations finance.yahoo.com - March 9 at 5:57 AM
	BerGenBio ASA: BerGenBio Announces Positive Data From Phase 2 Trial of Bemcentinib in Combination with Pembrolizumab in 2L+ NSCLC Patients finanznachrichten.de - February 17 at 5:54 PM
	BerGenBio Reports Fourth Quarter 2022 Financial Results and Provides Business Update finance.yahoo.com - February 16 at 10:49 AM
	BerGenBio Announces Positive Data From Phase 2 Trial of Bemcentinib in Combination with Pembrolizumab in 2L+ NSCLC Patients finance.yahoo.com - February 15 at 1:06 PM
	BerGenBio reports third quarter 2022 financial results and provides business update finance.yahoo.com - November 15 at 12:11 PM
	BerGenBio ASA Secures NOK 100 million Shareholder Loan Facility from Meteva AS prnewswire.com - October 25 at 1:40 AM
	BerGenBio Announces Initiation of Phase 1b/2a Trial Evaluating Bemcentinib in 1st line Non-Small Cell Lung Cancer Patients Harboring STK11 Mutations finance.yahoo.com - October 11 at 10:01 AM
	BERGENBIO ANNOUCES FIRST PATIENT RANDOMIZED IN BEMCENTINIB TRIAL IN EU-SOLIDACT PLATFORM FOR HOSPITALIZED COVID-19 PATIENTS finance.yahoo.com - September 27 at 10:50 AM
	BGBIO.OL - Bergenbio ASA \| Stock Price & Latest News \| Reuters reuters.com - September 10 at 5:10 AM
	BerGenBio reports second quarter and half year 2022 financial results and provides business update finance.yahoo.com - August 23 at 5:31 AM
	BerGenBio strengthens its leadership team with appointment of Cristina Oliva as Chief Medical Officer finance.yahoo.com - April 11 at 2:20 AM
	BERGENBIO ASA: BOARD APPROVAL OF 2021 ANNUAL FINANCIAL STATEMENT AND ANNUAL REPORT 2021 finance.yahoo.com - April 7 at 12:02 PM
	BERGENBIO ASA: RESULTS FOR THE FOURTH QUARTER AND FULL YEAR 2021 finance.yahoo.com - February 16 at 1:38 AM
	BerGenBio and Oslo University Hospital Announce the AXL Inhibitor Bemcentinib will be Studied in the EU Funded EU-SolidAct trial in Hospitalised COVID-19 Patients finance.yahoo.com - January 27 at 3:27 AM
	BRRGF Real-Time Quotes nasdaq.com - January 21 at 8:22 PM
	BRRGF Price/Earnings & PEG Ratios nasdaq.com - January 18 at 6:26 PM
	Bergenbio Presents Pre-clinical and Clinical Data on Bemcentinib in STK11-positive NSCLC at SITC Annual Meeting 2021 finance.yahoo.com - November 9 at 9:46 AM
	BerGenBio Receives FDA Fast Track Designation For Bemcentinib In STK11-mutated Advanced/Metastatic Non-small Lung Cancer (NSCLC) finance.yahoo.com - November 9 at 9:46 AM

Get BerGenBio ASA News Delivered to You Automatically

Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS (Ad)

You might have seen that Bitcoin was one of the best performing assets of 2023. It gained 164%. But a crypto millionaire who has been tracking the space for more than a decade has ABANDONED Bitcoin. He found something better.

Click here to find out that this 8,788% cryptocurrency is.

BRRGF Media Mentions By Week

BRRGF Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

BRRGF
News Sentiment
▼
0.00

0.52
▲
Average
Medical
News Sentiment

BRRGF News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

BRRGF Articles
This Week
▼
0

0
▲
BRRGF Articles
Average Week

Get BerGenBio ASA News Delivered to You Automatically

Related Companies and Tools

Related Companies:

Headlines Tools:

This page (OTCMKTS:BRRGF) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

BerGenBio ASA (BRRGF) News Today

BRRGF Media Mentions By Week

BRRGF Media Sentiment

BRRGF News Coverage

Related Companies and Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info